Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
About Praxis Precision Medicines
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain.
Company Facts
- Headquarters
- Cambridge
- Founded
- 2015
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00101_00250
- Funding Stage
- ipo
- Total Funding
- $1,673,117,750
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2026-01-06
- Website
- https://praxismedicines.com/
Industries & Categories
Alternative Medicine, Biotechnology, Health Care, Medical, Precision Medicine
Social Links
Canonical: https://fsome.com/organization/praxis-precision-medicines-5444 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.